Fig. 2From: Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trialstudy flowchart. CT = computed tomography; EOT = end of treatment; MRI = Magnetic resonance imaging; PET = positron emission tomography; PSA = Prostate-specific antigen; PSMA = prostate specific membrane antigen; SOC = standard of careBack to article page